Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Arcos Dorados Holdings
ARCO
$1.71B
| – | – |
-28,868
| Closed | -$170K |
|
3452
Aramark
ARMK
$16.1B
| – | – |
-318,135
| Closed | -$8.56M |
|
3453
Array Technologies
ARRY
$796M
| – | – |
-58,500
| Closed | -$913K |
|
3454
Associated Banc-Corp
ASB
$6.07B
| – | – |
-96,531
| Closed | -$1.98M |
|
3455
Ardmore Shipping
ASC
$707M
| – | – |
-141,772
| Closed | -$598K |
|
3456
AerSale
ASLE
$273M
| – | – |
-13,200
| Closed | -$164K |
|
3457
AdvanSix
ASIX
$446M
| – | – |
-48,000
| Closed | -$1.43M |
|
|
ASRT
3458
DELISTED
Assertio
ASRT
| – | – |
-45,439
| Closed | -$1.06M |
|
3459
Astec Industries
ASTE
$975M
| – | – |
-17,245
| Closed | -$1.08M |
|
|
ATHE
3460
Alterity Therapeutics
ATHE
$85.2M
| – | – |
-23,790
| Closed | -$309K |
|
3461
Autohome
ATHM
$2.6B
| – | – |
-229,600
| Closed | -$14.7M |
|
3462
Atomera
ATOM
$212M
| – | – |
-118,468
| Closed | -$2.54M |
|
3463
AptarGroup
ATR
$8.43B
| – | – |
-57,300
| Closed | -$8.07M |
|
3464
AngloGold Ashanti
AU
$48.1B
| – | – |
-37,500
| Closed | -$697K |
|
3465
AeroVironment
AVAV
$9.59B
| – | – |
-15,536
| Closed | -$1.56M |
|
3466
Axogen
AXGN
$2.58B
| – | – |
-44,700
| Closed | -$966K |
|
|
AZEK
3467
DELISTED
The AZEK Co
AZEK
| – | – |
-121,400
| Closed | -$5.16M |
|
3468
Bally's
BALY
$660M
| – | – |
-109,700
| Closed | -$5.94M |
|
3469
Credicorp
BAP
$29.8B
| – | – |
-147,300
| Closed | -$17.8M |
|
3470
Banco Bradesco
BBD
$34.3B
| – | – |
-15,381,310
| Closed | -$71.7M |
|
3471
Bath & Body Works
BBWI
$3.76B
| – | – |
-1,011,412
| Closed | -$58.9M |
|
|
BCLI
3472
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| – | – |
-3,173
| Closed | -$181K |
|
|
BCYC
3473
Bicycle Therapeutics
BCYC
$279M
| – | – |
-14,600
| Closed | -$443K |
|
3474
Bloom Energy
BE
$69.6B
| – | – |
-328,600
| Closed | -$8.83M |
|
3475
Beam Therapeutics
BEAM
$2.74B
| – | – |
-16,500
| Closed | -$2.12M |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.